-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Edwards Lifesciences, Raises Price Target to $75

Benzinga·04/24/2025 12:17:10
Listen to the news
Baird analyst David Rescott maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $72 to $75.